Cynthia Hathaway
Psychiatric/Mental Health · Boerne, TXNPI 1760856298
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 225 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,620 and has fallen 99.2% since, to $13 in 2025.
Across 225 payments — averaging $18.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$847
- Lundbeck LLC$569
- Takeda Pharmaceuticals U.S.A., Inc.$484
- Teva Pharmaceuticals USA, Inc.$396
- Neurocrine Biosciences, Inc.$345
- Johnson & Johnson$311
- plus $1K from 12 others
What the payments were for
- Food & beverage$4,06697%
- Education$1363%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 61 | $847 |
| Lundbeck LLC | 32 | $569 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $484 |
| Teva Pharmaceuticals USA, Inc. | 19 | $396 |
| Neurocrine Biosciences, Inc. | 16 | $345 |
| Johnson & Johnson | 13 | $311 |
| Otsuka America Pharmaceutical, Inc. | 12 | $299 |
| Bausch Health US, LLC | 17 | $297 |
| Corium, LLC | 7 | $165 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $159 |
| Almatica Pharma LLC | 5 | $78 |
| Merck | 5 | $78 |
| Arbor Pharmaceuticals, Inc. | 3 | $45 |
| Eisai Inc. | 2 | $44 |
| Idorsia Pharmaceuticals US Inc | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $15 |
| Cequr Corporation | 1 | $13 |
How this compares
$4,202 in reported general payments places this provider in the 85th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 11 | $777 |
| Guanfacine Hcl ErGuanfacine Hcl | 11 | $497 |
| Gabapentin | 17 | $333 |
| Aripiprazole | 15 | $319 |
| Escitalopram Oxalate | 12 | $267 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Boerne
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
- Marguerite AddisonWaco$118K
- Komi Kokou-AbiRound Rock$88K
- Jaime Nelson DensonAustin$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.